Selected article for: "comparison test and multiple comparison test"
Author: Brian G. Pierce; Zhen-Yong Keck; Ruixue Wang; Patrick Lau; Kyle Garagusi; Khadija Elkholy; Eric A. Toth; Richard A. Urbanowicz; Johnathan D. Guest; Pragati Agnihotri; Melissa C. Kerzic; Alexander Marin; Alexander K. Andrianov; Jonathan K. Ball; Roy A. Mariuzza; Thomas R. Fuerst; Steven K.H. Foung
Title: Structure-based design of hepatitis C virus E2 glycoprotein improves serum binding and cross-neutralization
  • Document date: 2020_4_17
    • ID: b6to1v4u_73
    Snippet: P-values between group endpoint titers and group ID50 values were calculated using Kruskal-Wallis one-way analysis of variance (ANOVA), with Dunn's multiple comparison test, in Graphpad Prism software. Asterisks denote designs that were tested in the context of ΔHVR1411 (aa 411-661) sE2 rather than full length sE2 (384-661). Immunized sera were tested for binding to H77C E1E2 and HCVpp representing H77C, UKNP1.18.1, and J6 isolates using ELISA. .....
    Document: P-values between group endpoint titers and group ID50 values were calculated using Kruskal-Wallis one-way analysis of variance (ANOVA), with Dunn's multiple comparison test, in Graphpad Prism software. Asterisks denote designs that were tested in the context of ΔHVR1411 (aa 411-661) sE2 rather than full length sE2 (384-661). Immunized sera were tested for binding to H77C E1E2 and HCVpp representing H77C, UKNP1.18.1, and J6 isolates using ELISA. Serum binding was tested at three-fold dilutions starting at 1:100, and values are reported as endpoint titers. Due to insufficient sera, endpoint titers author/funder. All rights reserved. No reuse allowed without permission.

    Search related documents:
    Co phrase search for related documents
    • ANOVA variance and Graphpad Prism software: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • ANOVA variance and Graphpad Prism software multiple comparison test: 1
    • ANOVA variance and multiple comparison: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • ANOVA variance and multiple comparison test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • endpoint titer and fold dilution: 1
    • endpoint titer and Graphpad Prism software: 1, 2
    • endpoint titer and Graphpad Prism software multiple comparison test: 1
    • endpoint titer and group endpoint titer: 1
    • endpoint titer and insufficient sera: 1
    • endpoint titer and multiple comparison: 1, 2
    • endpoint titer and multiple comparison test: 1, 2
    • fold dilution and group endpoint titer: 1
    • fold dilution and insufficient sera: 1
    • fold dilution and multiple comparison: 1
    • fold dilution and multiple comparison test: 1
    • Graphpad Prism software and multiple comparison: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • Graphpad Prism software and multiple comparison test: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • Graphpad Prism software and serum binding: 1
    • Graphpad Prism software multiple comparison test and multiple comparison: 1, 2, 3